Immunoreactive thymosin alpha 1 is associated with murine T-cell lymphomas.
Zatz. M M MM; McClure. J E JE; Goldstein. A L AL
Key Findings
- T‑cell lymphoma growth in mice raises serum immunoreactive thymosin‑alpha‑1
- The increase is tumor‑derived, not produced by the thymus
- B‑cell lymphomas do not cause elevated thymosin‑alpha‑1
Practical Outcomes
- For biohackers and longevity enthusiasts, this study offers no actionable insight. It suggests thymosin‑alpha‑1 isn’t a useful supplement for healthy people and has no direct relevance to performance or metabolic health protocols.
Summary
In mice with T‑cell lymphomas, the blood level of a peptide called thymosin‑alpha‑1 goes up, but this rise comes from the tumor itself, not the thymus. B‑cell lymphomas don’t cause this increase, so the peptide seems linked specifically to T‑cell cancers in these animals.
Abstract
Growth of murine spontaneous and transplanted AKR T-cell lymphomas results in marked elevations of serum immunoreactive thymosin alpha 1. Thymosin alpha 1 is one of the peptide hormones believed to be secreted primarily by the thymic epithelium. This elevation, however, is not mediated by the thymus but rather, seems to be directly associated with the tumor cells. Growth of a B-cell lymphoma does not generate elevated immunoreactive thymosin alpha 1 in the serum, thus, a thymosin alpha 1-like peptide is selectively associated with these T-cell lymphomas. The possible relationship between expression of T-leukemia viruses and alpha 1 expression is discussed.
Study Information
pubmed
1984
10.1016/0145-2126(84)90054-7
2
37